[Genetically determined variations in drug response (author's transl)].
D000123:Acetyltransferases / Q000378:metabolism; D000818:Animals; D001049:Apnea / Q000628:therapy; D002091:Butyrylcholinesterase / Q000378:metabolism / Q000627:therapeutic use; D002802:Cholinesterases / Q000378:metabolism / Q000627:therapeutic use; D014644:Genetic Variation; D005955:Glucosephosphate Dehydrogenase Deficiency / Q000235:genetics; D006455:Hemoglobins, Abnormal / Q000378:metabolism; D006801:Humans; D008708:Methemoglobinemia / Q000139:chemically induced; D009154:Mutation; D010278:Parathion / Q000506:poisoning; D004364:Pharmaceutical Preparations / Q000378:metabolism; D010597:Pharmacogenetics; D010615:Phenacetin / Q000009:adverse effects; D011110:Polymorphism, Genetic; D013045:Species Specificity; D013390:Succinylcholine / Q000378:metabolism
D006455:Hemoglobins, Abnormal; D004364:Pharmaceutical Preparations; D010278:Parathion; D000123:Acetyltransferases; D002091:Butyrylcholinesterase; D002802:Cholinesterases; D010615:Phenacetin; D013390:Succinylcholine